$2.835
-0.035[-1.22%]
Last update: 11:34AM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$2.88
0.0450[1.59%]
| Open2.870 | Close- |
| Vol / Avg.90.268K / 1.001M | Mkt Cap146.216M |
| Day Range2.810 - 2.920 | 52 Wk Range1.180 - 6.850 |
Black Diamond Therapeutic Stock (NASDAQ:BDTX), Key Statistics
Black Diamond Therapeutic Stock (NASDAQ: BDTX) analysis, key statistics.
Valuation Measures
Enterprise Value
85.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
1.81
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-79.17%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.59
Tangible Book value per share
1.59
Total Liabilities (Quarterly)
37.7M
Total Assets
119.9M
Total Liabilities
37.7M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Black Diamond Therapeutic Stock (NASDAQ:BDTX), Key Statistics
Black Diamond Therapeutic Stock (NASDAQ: BDTX) analysis, key statistics.
Valuation Measures
Enterprise Value
85.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
1.81
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-79.17%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.59
Tangible Book value per share
1.59
Total Liabilities (Quarterly)
37.7M
Total Assets
119.9M
Total Liabilities
37.7M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Black Diamond Therapeutic Stock (NASDAQ:BDTX), Key Statistics
Black Diamond Therapeutic Stock (NASDAQ: BDTX) analysis, key statistics.
Valuation Measures
Enterprise Value
85.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
1.81
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-79.17%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.59
Tangible Book value per share
1.59
Total Liabilities (Quarterly)
37.7M
Total Assets
119.9M
Total Liabilities
37.7M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Black Diamond Therapeutic Stock (NASDAQ:BDTX), Key Statistics
Black Diamond Therapeutic Stock (NASDAQ: BDTX) analysis, key statistics.
Valuation Measures
Enterprise Value
85.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
1.81
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-79.17%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.59
Tangible Book value per share
1.59
Total Liabilities (Quarterly)
37.7M
Total Assets
119.9M
Total Liabilities
37.7M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Black Diamond Therapeutic Stock (NASDAQ:BDTX), Key Statistics
Black Diamond Therapeutic Stock (NASDAQ: BDTX) analysis, key statistics.
Valuation Measures
Enterprise Value
85.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
1.81
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-79.17%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.59
Tangible Book value per share
1.59
Total Liabilities (Quarterly)
37.7M
Total Assets
119.9M
Total Liabilities
37.7M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Black Diamond Therapeutic Stock (NASDAQ:BDTX), Key Statistics
Black Diamond Therapeutic Stock (NASDAQ: BDTX) analysis, key statistics.
Valuation Measures
Enterprise Value
85.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
1.81
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-79.17%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.59
Tangible Book value per share
1.59
Total Liabilities (Quarterly)
37.7M
Total Assets
119.9M
Total Liabilities
37.7M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Black Diamond Therapeutic Stock (NASDAQ:BDTX), Key Statistics
Black Diamond Therapeutic Stock (NASDAQ: BDTX) analysis, key statistics.
Valuation Measures
Enterprise Value
85.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
1.81
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-79.17%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.59
Tangible Book value per share
1.59
Total Liabilities (Quarterly)
37.7M
Total Assets
119.9M
Total Liabilities
37.7M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Black Diamond Therapeutic Stock (NASDAQ:BDTX), Key Statistics
Black Diamond Therapeutic Stock (NASDAQ: BDTX) analysis, key statistics.
Valuation Measures
Enterprise Value
85.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
1.81
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-79.17%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.59
Tangible Book value per share
1.59
Total Liabilities (Quarterly)
37.7M
Total Assets
119.9M
Total Liabilities
37.7M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Black Diamond Therapeutic Stock (NASDAQ:BDTX), Key Statistics
Black Diamond Therapeutic Stock (NASDAQ: BDTX) analysis, key statistics.
Valuation Measures
Enterprise Value
85.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
1.81
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-79.17%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.59
Tangible Book value per share
1.59
Total Liabilities (Quarterly)
37.7M
Total Assets
119.9M
Total Liabilities
37.7M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -